PROBLEMS OF ANTICOAGULATION THERAPY IN PATIENTS WITH CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION: ROLE OF RIVAROXABAN

Heart failure and atrial fibrillation are the two new epidemics of cardiovascular disease. Their frequent coincidence increases mortality rates mainly because of increased risk of thromboembolic events. The review focuses on epidemiology, mechanisms, prognosis in patients with heart failure and atrial fibrillation, approaches to the administration of direct oral anticoagulants and role of rivaroxaban.

Authors
Kobalava Z.D. , Villevalde S.V. , Troitskaya E.A.
Journal
Kardiologiia
Publisher
KlinMed Consulting
Language
Russian
Pages
33-41
Status
Published
DOI
10.18087/cardio.2447
Volume
58
Year
2018
Keywords
CHRONIC HEART FAILURE; ATRIAL FIBRILLATION; DIRECT ORAL ANTICOAGULANTS; RIVAROXABAN
Date of creation
19.10.2018
Date of change
22.03.2022
Short link
https://repository.rudn.ru/en/records/article/record/9142/
Share

Other records